Regulus Therapeutics Inc Asset Resilience Ratio

Latest as of March 2025: 21.26%

Regulus Therapeutics Inc asset resilience ratio. Regulus Therapeutics Inc (RGLS) has an Asset Resilience Ratio of 21.26% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RGLS days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$15.91 Million

Cash + Short-term Investments

Total Assets

$74.83 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Regulus Therapeutics Inc (2010–2024)

Asset resilience ratio of Regulus Therapeutics Inc from 2010 to 2024. This chart shows how Regulus Therapeutics Inc's Asset Resilience Ratio has changed over time. Read Regulus Therapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Regulus Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Regulus Therapeutics Inc total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$15.91 Million	21.26%
Total Liquid Assets	$15.91 Million	21.26%

Asset Resilience Insights

Good Liquidity Position: Regulus Therapeutics Inc maintains a healthy 21.26% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Regulus Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Regulus Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Regulus Therapeutics Inc Asset Resilience Ratio by Year (2010–2024)

Regulus Therapeutics Inc asset resilience ratio by year from 2010 to 2024. The table below shows the annual Asset Resilience Ratio data for Regulus Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	44.25%	$37.25 Million	$84.18 Million	--
2023-12-31	0.00%	$0.00	$30.75 Million	--
2022-12-31	31.96%	$14.93 Million	$46.72 Million	--
2021-12-31	0.00%	$0.00	$68.45 Million	--
2018-12-31	0.00%	$0.00	$27.93 Million	--
2017-12-31	59.83%	$46.55 Million	$77.81 Million	-0.94pp
2016-12-31	60.77%	$61.17 Million	$100.66 Million	-8.77pp
2015-12-31	69.54%	$98.10 Million	$141.08 Million	-1.85pp
2014-12-31	71.39%	$122.42 Million	$171.48 Million	-6.78pp
2013-12-31	78.17%	$96.20 Million	$123.06 Million	+22.58pp
2012-12-31	55.59%	$57.55 Million	$103.52 Million	-11.96pp
2011-12-31	67.56%	$28.97 Million	$42.88 Million	+11.41pp
2010-12-31	56.15%	$33.52 Million	$59.70 Million	--

pp = percentage points

About Regulus Therapeutics Inc

NASDAQ:RGLS USA Biotechnology

Market Cap

$564.95 Million

Market Cap Rank

#11253 Global

#2939 in USA

Share Price

$8.16

Change (1 day)

+0.00%

52-Week Range

$8.16 - $8.16

All Time High

$1269.60